Conavi Medical Reports Fiscal Q2 2025 Interim Results and Operational Highlights

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced its financial results for the fiscal quarter ended March 31, 2025.

Read more at globenewswire.com